Join to View Full Profile
60 Temple StSte 8BNew Haven, CT 06510
Phone+1 203-401-4300
Dr. Seibyl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Nuclear Medicine, 1992 - 1994- Yale-New Haven Medical CenterResidency, Psychiatry, 1986 - 1990
Greenwich Hospital/Yale UniversityResidency, Internal Medicine, 1985 - 1986
Case Western Reserve University School of MedicineClass of 1986
Certifications & Licensure
CT State Medical License 1988 - 2024
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease Start of enrollment: 2005 Jan 01
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN) Start of enrollment: 2004 Mar 01
- Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects Start of enrollment: 2006 Apr 01
Publications & Presentations
PubMed
- Biomarkers.Vijaya L Reddy, Jesse M Cedarbaum, John Seibyl, Kara Mead, Erika Renkl
Alzheimer's & Dementia. 2025-12-01 - Characterizing Parkinson's Disease Clinical and Biomarker Interactions in REM Sleep Behavior Disorder.Vijaya L Reddy, Samantha Esposito, Erika Renkl, Amine Benyakoub, Kara Mead
Medrxiv. 2025-06-23 - Inflamed Microglia like Macrophages in the Central Nervous System of Prodromal Parkinson's Disease.Le Zhang, Yoshiaki Yasumizu, M Elizabeth Deerhake, Jeonghyeon Moon, Nicholas Buitrago-Pocasangre
Biorxiv. 2025-05-21
Journal Articles
- Assessment of 18f-PI-2620 as a Biomarker in Progressive Supranuclear PalsyJohn Seibyl, MD, JAMA Neurology
Press Mentions
CWRU Alumni Give $7.5 Million to Case Western Reserve University for Research into Parkinson’s, Alzheimer’s and Multiple SclerosisJune 7th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
